French Sanofi, UK's GSK Win US Funding For COVID-19 Vaccine
Sumaira FH Published July 31, 2020 | 09:51 PM
The US government's Operation Warp Speed partnership has chosen the vaccine candidate developed jointly by France's Sanofi and UK's GSK pharmaceutical companies as the subject to funding the production and delivery of 100 million doses of the COVID-19 vaccine to the US, Sanofi announced on Friday
MOSCOW (UrduPoint News / Sputnik - 31st July, 2020) The US government's Operation Warp Speed partnership has chosen the vaccine candidate developed jointly by France's Sanofi and UK's GSK pharmaceutical companies as the subject to funding the production and delivery of 100 million doses of the COVID-19 vaccine to the US, Sanofi announced on Friday.
Operation Warp Speed is the US state program that aims to accelerate the development and distribution of safe and effective COVID-19 vaccines.
"Sanofi and GSK today announce a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine," the statement published by Sanofi read.
According to the statement, the project will receive an up to $2.1 billion package from the US authorities, the majority of which will go to Sanofi.
The US government funding is aimed at the further development of the vaccine, including clinical trials and an initial supply of 100 million doses of the potential vaccine. As part of its Operation Warp Speed program, the US gets to receive an additional delivery of 500 million doses longer term.
The Sanofi-GSK vaccine is a combined product of the recombinant protein-based technology used by Sanofi for an influenza vaccine, and GSK's established pandemic adjuvant technology.
The statement also said that the companies were carrying out discussions with the European Commission and other governments and global health organizations so that the potential vaccine would be available globally.
Earlier this week, the UK government signed a deal for 60 million doses of the COVID-19 vaccine developed under the Sanofi and GSK joint project.
Related Topics
Recent Stories
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
More Stories From World
-
Japan anime studio draws on talent of autistic artists
31 seconds ago -
Pakistan needs strong defence in view of its location in 'rough' neighbourhood: Masood Khan
46 seconds ago -
Bangladesh children sweat at home as heatwave shuts schools
11 minutes ago -
Iconic shared Olympic gold moment will not be repeated, says Barshim
11 minutes ago -
Bangladesh children sweat at home as heatwave shuts schools
41 minutes ago -
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leave after 20 years of ..
1 hour ago
-
Golf: PGA Zurich Classic of New Orleans scores
1 hour ago -
Slot 'confident' of Liverpool job as 'negotiations' take place
7 hours ago -
Google parent Alphabet's Q1 profits beat estimates: company
7 hours ago -
WADA asks 'independent prosecutor' to examine Chinese swimmers case
7 hours ago -
New York court overturns Harvey Weinstein sex crime conviction
8 hours ago -
Bagnaia and Spanish rivals chase victory at Jerez
9 hours ago